# Integrating Buprenorphine Into the SFGH AIDS Program

> **NCT00263458** · PHASE4 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 37 (actual)

## Conditions studied

- HIV
- Buprenorphine
- Opioid Dependence

## Interventions

- **OTHER:** Integrated office-based buprenorphine treatment for opioid dependence in an HIV primary care setting

## Key facts

- **NCT ID:** NCT00263458
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2011-09-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00263458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00263458, "Integrating Buprenorphine Into the SFGH AIDS Program". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00263458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*